Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Measuring What Matters in Diabetes

Measuring What Matters in Diabetes This Viewpoint discusses the inadequacy of hemoglobin A1c levels as a marker of effects of treatment on clinically important diabetes outcomes, and argues for replacing it with measures of treatment effects important to patients and their caregivers, such as hyperglycemia and hypoglycemia, vision deterioration, neuropathy and ulceration, diabetes distress, and treatment-related financial hardship. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Measuring What Matters in Diabetes

JAMA , Volume 321 (19) – May 21, 2019

Loading next page...
 
/lp/american-medical-association/measuring-what-matters-in-diabetes-UJ28LRxQ7i
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2019.4310
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint discusses the inadequacy of hemoglobin A1c levels as a marker of effects of treatment on clinically important diabetes outcomes, and argues for replacing it with measures of treatment effects important to patients and their caregivers, such as hyperglycemia and hypoglycemia, vision deterioration, neuropathy and ulceration, diabetes distress, and treatment-related financial hardship.

Journal

JAMAAmerican Medical Association

Published: May 21, 2019

References